EX-10.7 8 ex10-7.htm

 

展览10.7

 

压力位 协议

 

本 压力位协议(本“协议”),日期为2024年9月24日(“生效日期。”),由Delaware集团Eterna Therapeutics Inc.公司(“公司”),以及在签名页下方“股东”标题下列出的股东 之间达成。股东名称”).

 

鉴于,公司正在与购买方就证券购买协议(“SPA”),以生效日期为准,进行交易;根据该协议,公司同意发行并卖出给购买方,而购买方同意购买公司普通股,每股面值0.005美元(“普通股”)和预先拟发行的权证来购买普通股;

 

而, 公司正在签订交换协议(”交换协议”),日期自生效之日起, 可转换票据(定义见交易协议)和/或认股权证(定义见交易协议)的持有人 除其他外,此类持有人将在不附带所有留置权的情况下向公司转让、交付、转让和转让,每个: (i) 交换票据(定义见交换协议),以换取有效发行、已全额支付和不可估税的普通股 按其中规定的交换比率计算的股票;以及 (ii) 交换认股权证(定义见交易协议)以换取有效的 按其中规定的交换比率已发行、已全额支付和不可评估的普通股;

 

鉴于, 公司正在与购买方签署《票据购买协议》(以下简称“NPA”),日期为生效日期,根据协议,公司同意向购买方发行和出售12.0%优先可转换票据(以下简称“桥梁票据净有形资产完成条件

 

鉴于,作为公司愿意进入并诱使公司进入SPA、交易所协议和NPA(统称为“条件”的条件,公司希望股东同意并股东同意签订本协议。交易协议并完成其中所 contempla transactions 部交易,公司希望股东同意,股东同意进入本协议。

 

现在, 因此,在考虑上述内容以及本协议中包含的相互约定和协议,并有意在此受法律约束的前提下,各方特此同意如下:

 

第一条
投票协议

 

1.1 投票协议股东在执行和交付本协议的期间开始并持续直到根据本协议终止,同意以下内容 第4.1节无论股东公司股东大会如何召开,在任何由公司提出的股东书面同意行动中,股东应: (a)投票并确保其关联方投票,所有股东或其关联方有权投票的受覆盖证券(如下定义)应赞成或代表其自身及其所有关联方同意证券发行提案(如股份购买协议中定义);及(b)投票,并确保其关联方投票,所有股东或其关联方有权投票的受覆盖证券应反对或拒绝(代表其自身及其受控关联方)同意任何可能与证券发行提案相冲突、阻碍、延误、干扰或以其他方式对案件协议中所述交易的批准造成不利影响或延误的提案或任何其他公司行动或协议,或可能导致公司违反案件协议。为了前述目的,股东应在公司向其股东发送代理声明(如股份购买协议中定义)后第五天(或有效日期)向公司交付一份填妥的授权书,填写形式由公司或代表公司分发,赞成证券发行提案。对于本协议,"覆盖证券意味着(i)自生效日期起由股东和/或其关联方拥有的所有普通股,以及在自生效日期后由股东和/或其关联方取得的所有普通股和(ii)自生效日期起股东或其关联方有权投票或在自生效日期起后有权投票的任何其他证券(如果有)公司股东大会。在本协议终止之前发生任何股息或分配,或者由于任何股息或分配、股票分割、资本变动、合并、兼并、转换等导致公司资本股本变化,术语"受覆盖证券"应视为指代并包括所述股息和分配以及所述股份的任何变化或交换而或为其而获得的任何证券在内。

 

1.2 关于其他事项的投票尽管任何规定 为了本计划的目的,以下术语应具有以下含义: 相反,除非在涉及Covered证券投票的任何其他协议中另有规定,股东应保持按照其认为适当的方式就Covered证券进行投票或签署同意书 为了本计划的目的,以下术语应具有以下含义: 股东可自行决定就股票问题进行投票或签署同意书,视情形而定。

 

 

 

 

第2条
股东的陈述和保证

 

股东 在此向公司陈述并保证如下:

 

2.1 权限 相对于本协议股东具有签署和交付本协议,履行其在此项下的义务,以及完成本协议项下所 contempl,的交易所需的所有必要的法律能力、权力和权威。本协议已由股东依法签署和交付,并构成股东的合法、有效和具有约束力的义务,可依其条款对股东执行,但(a)若强制执行可能受限于适用的破产、破产清算、重组、欺诈转让、停赋或类似法律,现有或今后生效,涉及或一般影响债权人和其他债权人权利的执行,(b)在特定执行或其他形式的衡平救济措施可能受到特定衡平抗辩原则和法院决定的合理裁量权之情况下,以及(c) 在适用法律和公共政策的限制下,赔偿和贡献的权利可能受到限制。股东已收到并审阅了交易协议和交易文件(在SPA和NPA中定义)。

 

2.2 无冲突.

 

2.2.1 股东执行和交付本协议,不会,股东履行本协议时不会, (i)与或违反任何适用于股东或影响或影响被覆盖证券的任何外国、联邦、州或地方法律、法规、法案或法令、规章、规定、命令、判决或法令或(ii)违反, 任何违约(或一个随通知或时间的流逝或两者都会变为违约的事件)或导致他人获得终止、修改、加速或撤消的权利,或导致设定留置权、抵押、抵押、选择权、 担保权益、担保、税款、优先购买权或其他限制(统称为“担保机构”)对任何被覆盖证券的任何票据、债券、抵押、债券、契约、协议、 租约、许可证、特许经营权或其他证书或义务的产生,除了在上述第(i)和(ii)款中,任何这样的冲突、违约、终止、修改、加速、撤消或留置权可能 不能愉快地预期,单独或累计地,防止、 实质性地延误或实质性地损害股东履行本协议的能力。

 

2.2.2 Stockholder执行和交付本协议不需要,Stockholder执行本协议也不需要得到任何政府实体的同意、批准、授权或许可,也不需要向任何政府实体提交申报或通知。

 

2.3 股票名称。在生效日期,股东拥有所附列之普通股股数作为业主。 附录A 随文附上。此普通股股份代表股东截至生效日期拥有的所有普通股,不论为记录所有或有益所有,但除尚未于生效日期兑换或执行的任何衍生证券以取得普通股。此普通股股份的持有不受任何种类任何形式对股东表决权的任何质权或限制,但须除外(a) 本协议下之限制或限制,(b) 依据适用证券法所加之任何限制或限制,或(c) 任何限制或限制,合理来看,无论个别或合计,均不会防碍、实质延误或实质损害股东履行本协议下之义务。股东尚未就任何涵盖证券任命或授予任何透过授权委托代理的,而此等授予仍有效。

 

文章 3
契约条款

 

3.1 不 股票处分。股东谨此承诺并同意,在根据本协议终止之前,根据 第 4.1,股东不得提供或同意转让、过户、提供、转让、质押、抵押或以其他方式处置、授予 有关的代理权或授权书,或创建或允许存有任何对股东投票 权利造成限制的抵押权或限制(除适用证券法律强加的任何限制或规定)对于被覆盖的证券; 提供, 但是兆.股东可以转让、卖出或转让任何被覆盖的 证券,前提是接受该等被覆盖证券的收件人已向公司提交了一份公司合理满意的书面协议,规定接收方应受到约束,并且转让、转让 或卖出的被覆盖证券应继续受本协议的约束。

 

3.2 公司 合作公司谨此立约并同意,不会认可任何对任何已被覆盖的证券设定的留置权,并且股东不可撤回及无条件地承认并同意公司不会(并放弃与公司有关此事的任何权利),除非已遵守 第3.1节 的规定。

 

2

 

 

第4条(需理解,对于参考资产中不包含普通股(无分证)或与其有关之存托凭证的任何部分,无需进行此调整)。如果在任何合并事项情况下,参考资产包括股票、证券或其他财产或资产(包括现金或其组合)属于公司或继任人或购买人以外的人,则该其他人应同样签署此修正案,并且该修正案应包含董事会认为合理的保护持有人利益的附加条款。
杂项

 

4.1 终止。 本协议应自动终止,无需进一步采取行动,在最早发生以下情况之一时,即(a) 在公司获得股东批准(按照股权控股协议(SPA)中的定义)之后立即跟随,和 (b) 根据其条款终止所有交易协议时无效。

 

4.2 进一步保证股东将执行并交付进一步的文件和工具,并采取所有合理必要的行动,以便完成本合约所构思的交易。

 

4.3 特定 表现。 公司有权根据本协议要求特定履约。各方一致同意,有鉴于违反本协议内容可能导致的损失,金钱赔偿可能无法足够补偿,并且在任何要求执行此等义务的诉讼中同意放弃及不主张军工股为适当补救的辩护。

 

4.4 整个协议。本协议涵盖了双方对于本协议主题的整体理解,并取代了所有先前有关该事项的口头或书面协议和理解,双方承认这些协议已合并入本协议中。

 

4.5 修订;豁免任何本协议的条款均不得放弃、修改、补充或修改,除非透过公司和股东签署的书面文件。对于本协议的任何条款、控制项或要求的放弃不应被视为将来的持续放弃,或任何后续违约的放弃,或任何其他条款、控制项或要求的放弃,也不应被任何一方延迟或遗漏行使此处的任何权利以任何方式损害行使任何此类权利。

 

4.6 可分割性。 如果本协议的任何条款、规定、承诺或限制被有管辖权的法院裁定为无效、非法、无效或不可执行,本协议中所载的余下的条款、规定、承诺和限制将继续生效,并且不会受到影响、损害或无效,且本方将尽商业上合理的努力找到并使用替代手段以达到或基本达到该条款、规定、承诺或限制所预期的同等或基本相同的结果。双方特此约定及声明,其意图是,即使有可能后来被宣告无效、非法、无效或不可执行的条款、规定、承诺或限制,他们仍会执行其余的条款、规定、承诺和限制,而不包括任何可能后来被宣告无效、非法、无效或不可执行的内容。

 

4.7 Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is delivered via email to the email address set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on a Trading Day (as such term is defined in the SPA), (b) the next Trading Day after the time of transmission, if such notice or communication is delivered via email to the email address set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages attached hereto.

 

4.8 Governing Law; Jurisdiction; Waiver of Jury Trial. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof that would result in the application of the laws of any jurisdiction other than the State of New York. Each party agrees that all actions, claims, suits, disputes or proceedings (collectively, “Actions”) concerning the interpretations, enforcement and defense of the transactions contemplated by this Agreement (whether brought against a party hereto or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of this Agreement), and hereby irrevocably waives, and agrees not to assert in any Action, any claim that it is not personally subject to the jurisdiction of any such court, that such Action is improper or is an inconvenient venue for such Action. Each party hereby irrevocably waives personal service of process and consents to process being served in any such Action by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party shall commence an Action to enforce any provisions of the Agreement, then the prevailing party in such Action shall be reimbursed by the non-prevailing party for its reasonable attorneys’ fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Action. IN ANY ACTION IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST THE OTHER, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.

 

4.9 Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day (as such term is defined in the SPA), then such action may be taken or such right may be exercised on the next succeeding Business Day.

 

4.10 Construction. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise this Agreement and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed in the interpretation of this Agreement or any amendments thereto.

 

4.11 Headings. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions hereof.

 

4.12 Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns. Stockholder may not assign this Agreement or any rights or obligations hereunder without the prior written consent of the Company.

 

4.13 Execution. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by electronic signature (including via DocuSign) or by e-mail delivery of a “.pdf” (or similar) format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such electronic or “.pdf” (or similar) signature page were an original thereof.

 

[Signature page follows]

 

3

 

 

IN WITNESS WHEREOF, Stockholder and the Company have duly executed this Agreement as of the Effective Date.

 

ETERNA THERAPEUTICS INC.

 

 

Address for Notice:

 

Eterna Therapeutics Inc.

Attention: CEO

1035 Cambridge Street, Suite 18A, Cambridge, Massachusetts 02141

 

By: /s/ Sanjeev Luther Email: sanjeev.luther@eternatx.com
Name: Sanjeev Luther  
Title: President and Chief Executive Officer  

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK

SIGNATURE PAGE FOR STOCKHOLDER FOLLOWS]

 

4

 

 

[STOCKHOLDER SIGNATURE PAGE TO SUPPORT AGREEMENT]

 

IN WITNESS WHEREOF, Stockholder and the Company have duly executed this Agreement as of the Effective Date.

 

Name of Stockholder

 

 

Signature of Authorized Signatory of Stockholder

 

 

Name of Authorized Signatory

 

 

Title of Authorized Signatory

 

 

Email Address of Authorized Signatory

 

 

Address for Notice to Stockholder

 

 
   
   

Email

 

 

 

5

 

 

APPENDIX A

 

Stockholder Number of Shares of
Common Stock
Owned as of the Effective Date

 

6